Home >> Life Sciences >>

Global Neurological Disorder Drugs Market Report 2018 - Industry Research Report

Published: Jun-2018 | Format: PDF | Maia Research | Number of pages: 115 | Code: MRS - 269125

The Neurological Disorder Drugs market revenue was xx.xx Million USD in 2013, grew to xx.xx Million USD in 2017, and will reach xx.xx Million USD in 2023, with a CAGR of x.x% during 2018-2023. Based on the Neurological Disorder Drugs industrial chain, this report mainly elaborate the definition, types, applications and major players of Neurological Disorder Drugs market in details. Deep analysis about market status (2013-2018), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2018-2023), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Neurological Disorder Drugs market.
The Neurological Disorder Drugs market can be split based on product types, major applications, and important regions.
 
Major Players in Neurological Disorder Drugs market are:
Merck & Co.
Bayer AG
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
AstraZeneca
F. Hoffmann-La Roche Ltd.
Novartis AG
 
Major Regions play vital role in Neurological Disorder Drugs market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Neurological Disorder Drugs products covered in this report are:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others

Most widely used downstream fields of Neurological Disorder Drugs market covered in this report are:
Hospital
Clinic
Home

There are 13 Chapters to thoroughly display the Neurological Disorder Drugs market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Neurological Disorder Drugs Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.

Chapter 2: Neurological Disorder Drugs Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.

Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Neurological Disorder Drugs.

Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Neurological Disorder Drugs.

Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Neurological Disorder Drugs by Regions (2013-2018).

Chapter 6: Neurological Disorder Drugs Production, Consumption, Export and Import by Regions (2013-2018).

Chapter 7: Neurological Disorder Drugs Market Status and SWOT Analysis by Regions.

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Neurological Disorder Drugs.

Chapter 9: Neurological Disorder Drugs Market Analysis and Forecast by Type and Application (2018-2023).

Chapter 10: Market Analysis and Forecast by Regions (2018-2023).

Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.

Chapter 12: Market Conclusion of the Whole Report.

Chapter 13: Appendix Such as Methodology and Data Resources of This Research.
Global Neurological Disorder Drugs Industry Market Research Report
1 Neurological Disorder Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Definition of Neurological Disorder Drugs
1.3 Neurological Disorder Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Neurological Disorder Drugs Value ($) and Growth Rate from 2013-2023
1.4 Market Segmentation
1.4.1 Types of Neurological Disorder Drugs
1.4.2 Applications of Neurological Disorder Drugs
1.4.3 Research Regions
1.4.3.1 North America Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.2 Europe Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.3 China Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.4 Japan Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.5 Middle East & Africa Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.6 India Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.4.3.7 South America Neurological Disorder Drugs Production Value ($) and Growth Rate (2013-2018)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Neurological Disorder Drugs
1.5.1.2 Growing Market of Neurological Disorder Drugs
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies

2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of Neurological Disorder Drugs Analysis
2.2 Major Players of Neurological Disorder Drugs
2.2.1 Major Players Manufacturing Base and Market Share of Neurological Disorder Drugs in 2017
2.2.2 Major Players Product Types in 2017
2.3 Neurological Disorder Drugs Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Neurological Disorder Drugs
2.3.3 Raw Material Cost of Neurological Disorder Drugs
2.3.4 Labor Cost of Neurological Disorder Drugs
2.4 Market Channel Analysis of Neurological Disorder Drugs
2.5 Major Downstream Buyers of Neurological Disorder Drugs Analysis

3 Global Neurological Disorder Drugs Market, by Type
3.1 Global Neurological Disorder Drugs Value ($) and Market Share by Type (2013-2018)
3.2 Global Neurological Disorder Drugs Production and Market Share by Type (2013-2018)
3.3 Global Neurological Disorder Drugs Value ($) and Growth Rate by Type (2013-2018)
3.4 Global Neurological Disorder Drugs Price Analysis by Type (2013-2018)

4 Neurological Disorder Drugs Market, by Application
4.1 Global Neurological Disorder Drugs Consumption and Market Share by Application (2013-2018)
4.2 Downstream Buyers by Application
4.3 Global Neurological Disorder Drugs Consumption and Growth Rate by Application (2013-2018)

5 Global Neurological Disorder Drugs Production, Value ($) by Region (2013-2018)
5.1 Global Neurological Disorder Drugs Value ($) and Market Share by Region (2013-2018)
5.2 Global Neurological Disorder Drugs Production and Market Share by Region (2013-2018)
5.3 Global Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.4 North America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.5 Europe Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.6 China Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.7 Japan Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.8 Middle East & Africa Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.9 India Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)
5.10 South America Neurological Disorder Drugs Production, Value ($), Price and Gross Margin (2013-2018)

6 Global Neurological Disorder Drugs Production, Consumption, Export, Import by Regions (2013-2018)
6.1 Global Neurological Disorder Drugs Consumption by Regions (2013-2018)
6.2 North America Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.3 Europe Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.4 China Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.5 Japan Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.6 Middle East & Africa Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.7 India Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)
6.8 South America Neurological Disorder Drugs Production, Consumption, Export, Import (2013-2018)

7 Global Neurological Disorder Drugs Market Status and SWOT Analysis by Regions
7.1 North America Neurological Disorder Drugs Market Status and SWOT Analysis
7.2 Europe Neurological Disorder Drugs Market Status and SWOT Analysis
7.3 China Neurological Disorder Drugs Market Status and SWOT Analysis
7.4 Japan Neurological Disorder Drugs Market Status and SWOT Analysis
7.5 Middle East & Africa Neurological Disorder Drugs Market Status and SWOT Analysis
7.6 India Neurological Disorder Drugs Market Status and SWOT Analysis
7.7 South America Neurological Disorder Drugs Market Status and SWOT Analysis

8 Competitive Landscape
8.1 Competitive Profile
8.2 Merck & Co.
8.2.1 Company Profiles
8.2.2 Neurological Disorder Drugs Product Introduction
8.2.3 Merck & Co. Production, Value ($), Price, Gross Margin 2013-2018E
8.2.4 Merck & Co. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.3 Bayer AG
8.3.1 Company Profiles
8.3.2 Neurological Disorder Drugs Product Introduction
8.3.3 Bayer AG Production, Value ($), Price, Gross Margin 2013-2018E
8.3.4 Bayer AG Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.4 Teva Pharmaceutical Industries Ltd.
8.4.1 Company Profiles
8.4.2 Neurological Disorder Drugs Product Introduction
8.4.3 Teva Pharmaceutical Industries Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
8.4.4 Teva Pharmaceutical Industries Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.5 GlaxoSmithKline plc
8.5.1 Company Profiles
8.5.2 Neurological Disorder Drugs Product Introduction
8.5.3 GlaxoSmithKline plc Production, Value ($), Price, Gross Margin 2013-2018E
8.5.4 GlaxoSmithKline plc Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.6 Boehringer Ingelheim GmbH
8.6.1 Company Profiles
8.6.2 Neurological Disorder Drugs Product Introduction
8.6.3 Boehringer Ingelheim GmbH Production, Value ($), Price, Gross Margin 2013-2018E
8.6.4 Boehringer Ingelheim GmbH Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.7 AstraZeneca
8.7.1 Company Profiles
8.7.2 Neurological Disorder Drugs Product Introduction
8.7.3 AstraZeneca Production, Value ($), Price, Gross Margin 2013-2018E
8.7.4 AstraZeneca Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.8 F. Hoffmann-La Roche Ltd.
8.8.1 Company Profiles
8.8.2 Neurological Disorder Drugs Product Introduction
8.8.3 F. Hoffmann-La Roche Ltd. Production, Value ($), Price, Gross Margin 2013-2018E
8.8.4 F. Hoffmann-La Roche Ltd. Market Share of Neurological Disorder Drugs Segmented by Region in 2017
8.9 Novartis AG
8.9.1 Company Profiles
8.9.2 Neurological Disorder Drugs Product Introduction
8.9.3 Novartis AG Production, Value ($), Price, Gross Margin 2013-2018E
8.9.4 Novartis AG Market Share of Neurological Disorder Drugs Segmented by Region in 2017

9 Global Neurological Disorder Drugs Market Analysis and Forecast by Type and Application
9.1 Global Neurological Disorder Drugs Market Value ($) & Volume Forecast, by Type (2018-2023)
9.1.1 Antipsychotic Market Value ($) and Volume Forecast (2018-2023)
9.1.2 Hypnotic & Sedative Market Value ($) and Volume Forecast (2018-2023)
9.1.3 Analgesics Market Value ($) and Volume Forecast (2018-2023)
9.1.4 Anticoagulants Market Value ($) and Volume Forecast (2018-2023)
9.1.5 Others Market Value ($) and Volume Forecast (2018-2023)
9.2 Global Neurological Disorder Drugs Market Value ($) & Volume Forecast, by Application (2018-2023)
9.2.1 Hospital Market Value ($) and Volume Forecast (2018-2023)
9.2.2 Clinic Market Value ($) and Volume Forecast (2018-2023)
9.2.3 Home Market Value ($) and Volume Forecast (2018-2023)

10 Neurological Disorder Drugs Market Analysis and Forecast by Region
10.1 North America Market Value ($) and Consumption Forecast (2018-2023)
10.2 Europe Market Value ($) and Consumption Forecast (2018-2023)
10.3 China Market Value ($) and Consumption Forecast (2018-2023)
10.4 Japan Market Value ($) and Consumption Forecast (2018-2023)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2018-2023)
10.6 India Market Value ($) and Consumption Forecast (2018-2023)
10.7 South America Market Value ($) and Consumption Forecast (2018-2023)

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Research Finding and Conclusion

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

Single User | $(USD)2960 View Pricing